Daniel Delgado-Bellido

7PUBLICATIONS
25CO-AUTHORS
Molecular targetsMechanobiologyHaematological tumoursRegenerative medicine (incl. stem cells)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2025
EWS::FLI1-DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism.

Joaquin Olmedo-Pelayo, Esperanza Granado-Calle, Daniel Delgado-Bellido

|Feb 25, 2025
Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma.

Daniel Delgado-Bellido, Antonio Chacon-Barrado, Joaquin Olmedo-Pelayo

|Jun 10, 2023
VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation.

Daniel Delgado-Bellido, F J Oliver, María Victoria Vargas Padilla

|Feb 16, 2023
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry.

Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés

|Aug 12, 2022
Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell-Matrix Interactions.

Pilar Puerto-Camacho, Juan Díaz-Martín, Joaquín Olmedo-Pelayo

|Jun 10, 2022
Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System.

Ana Belén Herrera-Campos, Esteban Zamudio-Martinez, Daniel Delgado-Bellido

Pageof 2